Physician

Adam Zayac

According to 2025 Medicare claims, Adam Zayac (NPI: 1023428273) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1518904929; TIN: 223371727) and primary practice location at 08901-1992. Zayac is affiliated with the Englewood Health ACO, LLC (ACO ID: A5653), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Zayac's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 85 traditional Medicare patients, billed 277 HCPCS/CPT codes, and received $32,545 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 309 prescription claims across 35 beneficiaries totaling $836,133 in drug costs, led by Venclexta (Venetoclax). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $3,081 to $836,133. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.